Related Experiment Video
Updated: Jun 16, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Dynamin 2 and human diseases
Anne-Cécile Durieux1, Bernard Prudhon, Pascale Guicheney
1Inserm, UMR S974, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, F-75013, France.
Abstract:
Dynamin 2 (DNM2) mutations cause autosomal dominant centronuclear myopathy, a rare form of congenital myopathy, and intermediate and axonal forms of Charcot-Marie-Tooth disease, a peripheral neuropathy. DNM2 is a large GTPase mainly involved in membrane trafficking through its function in the formation and release of nascent vesicles from biological membranes. DNM2 participates in clathrin-dependent and clathrin-independent endocytosis and intracellular membrane trafficking (from endosomes and Golgi apparatus). Recent studies have also implicated DNM2 in exocytosis. DNM2 belongs to the machinery responsible for the formation of vesicles and regulates the cytoskeleton providing intracellular vesicle transport. In addition, DNM2 tightly interacts with and is involved in the regulation of actin and microtubule networks, independent from membrane trafficking processes. We summarize here the molecular, biochemical, and functional data on DNM2 and discuss the possible pathophysiological mechanisms via which DNM2 mutations can lead to two distinct neuromuscular disorders.
Insights
Mutations in Dynamin 2 (DNM2) cause rare neuromuscular disorders, centronuclear myopathy and Charcot-Marie-Tooth disease. This review explores DNM2's role in membrane trafficking and cytoskeleton regulation, linking its dysfunction to these distinct conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Neuroscience
Background:
- Dynamin 2 (DNM2) mutations are linked to autosomal dominant centronuclear myopathy and Charcot-Marie-Tooth disease.
- DNM2 is a GTPase crucial for membrane trafficking, including endocytosis and exocytosis.
- DNM2 also regulates cytoskeletal dynamics, interacting with actin and microtubule networks.
Purpose of the Study:
- To review the molecular, biochemical, and functional data on Dynamin 2.
- To discuss the pathophysiological mechanisms linking DNM2 mutations to neuromuscular disorders.
Main Methods:
- Literature review of molecular, biochemical, and functional studies on DNM2.
- Analysis of existing data on DNM2's role in membrane trafficking and cytoskeleton regulation.
- Discussion of mutation-induced pathophysiological pathways.
Main Results:
- DNM2 is essential for vesicle formation and intracellular transport.
- DNM2's functions extend beyond membrane trafficking to include cytoskeletal regulation.
- Mutations in DNM2 disrupt these fundamental cellular processes, leading to disease.
Conclusions:
- DNM2 plays a multifaceted role in cellular function, impacting both membrane dynamics and cytoskeletal organization.
- Dysregulation of DNM2 function through mutations provides a mechanistic link to centronuclear myopathy and Charcot-Marie-Tooth disease.
- Further research into DNM2's complex roles may reveal therapeutic targets for these neuromuscular conditions.
Related Concept Videos
Pinching-off of Coated Vesicles
Cardiomyopathy II: Dilated Cardiomyopathy
Cytoskeletal Linker Proteins - Plakins
Lysosomal Hydrolases
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

